# Omega Stock Market Value

OMGA | Stock | ## USD 5.58 0.21 3.91% |

Symbol | Omega |

Is Omega Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Therapeutics. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Omega Therapeutics is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Omega Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Therapeutics' market value can be influenced by many factors that don't directly affect Omega Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Omega Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Omega Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

## Omega Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Omega Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Omega Therapeutics.

08/06/2022 |
| 10/05/2022 |

If you would invest

**0.00**in Omega Therapeutics on**August 6, 2022**and sell it all today you would**earn a total of 0.00**from holding Omega Therapeutics or generate**0.0%**return on investment in Omega Therapeutics over**60**days. Omega Therapeutics is related to or competes with AKZO NOBEL, Sociedad Quimica, BRENNTAG, and Croda Intl. Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company More## Omega Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Omega Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Omega Therapeutics upside and downside potential and time the market with a certain degree of confidence.

Downside Deviation | 5.84 | |||

Information Ratio | 0.127 | |||

Maximum Drawdown | 34.15 | |||

Value At Risk | (8.38) | |||

Potential Upside | 9.97 |

## Omega Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Omega Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Omega Therapeutics' standard deviation. In reality, there are many statistical measures that can use Omega Therapeutics historical prices to predict the future Omega Therapeutics' volatility.Risk Adjusted Performance | 0.1591 | |||

Jensen Alpha | 0.801 | |||

Total Risk Alpha | 0.9893 | |||

Sortino Ratio | 0.1421 | |||

Treynor Ratio | 3.71 |

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Omega Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Omega Therapeutics in the context of predictive analytics.

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Omega Therapeutics. Your research has to be compared to or analyzed against Omega Therapeutics' peers to derive any actionable benefits. When done correctly, Omega Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Omega Therapeutics.

## Omega Therapeutics Backtested Returns

Omega Therapeutics appears to be unstable, given 3 months investment horizon. Omega Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0784, which implies the firm had 0.0784% of return per unit of risk over the last 3 months. Our standpoint towards forecasting the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Omega Therapeutics, which you can use to evaluate the future volatility of the company. Please evaluate Omega Therapeutics' Semi Deviation of 5.18, risk adjusted performance of 0.1591, and Coefficient Of Variation of 814.04 to confirm if our risk estimates are consistent with your expectations.

On a scale of 0 to 100, Omega Therapeutics holds a performance score of 5. The company holds a Beta of 0.214, which implies not very significant fluctuations relative to the market. Let's try to break down what Omega's beta means in this case. As returns on the market increase, Omega Therapeutics returns are expected to increase less than the market. However, during the bear market, the loss on holding Omega Therapeutics will be expected to be smaller as well. Although it is vital to follow Omega Therapeutics current trending patterns, it is good to be conservative about what you can do with the information regarding equity existing price patterns. The philosophy towards forecasting future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Omega Therapeutics technical indicators, you can presently evaluate if the expected return of 0.48% will be sustainable into the future. Please employ Omega Therapeutics information ratio, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance to make a quick decision on whether Omega Therapeutics historical price patterns will revert.

## Auto-correlation | -0.12 |

### Insignificant reverse predictability

Omega Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Omega Therapeutics time series from 6th of August 2022 to 5th of September 2022 and 5th of September 2022 to 5th of October 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Omega Therapeutics price movement. The serial correlation of

**-0.12**indicates that less than 12.0% of current Omega Therapeutics price fluctuation can be explain by its past prices.Correlation Coefficient | -0.12 | |

Spearman Rank Test | 0.05 | |

Residual Average | 0.0 | |

Price Variance | 0.22 |

## Omega Therapeutics lagged returns against current returns

Autocorrelation, which is Omega Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Omega Therapeutics' stock expected returns. We can calculate the autocorrelation of Omega Therapeutics returns to help us make a trade decision. For example, suppose you find that Omega Therapeutics stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.

Current and Lagged Values |

Share

Timeline |

## Omega Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Omega Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Omega Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Omega Therapeutics stock over time.

Current vs Lagged Prices |

Share

Timeline |

## Omega Therapeutics Lagged Returns

When evaluating Omega Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Omega Therapeutics stock have on its future price. Omega Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Omega Therapeutics autocorrelation shows the relationship between Omega Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Omega Therapeutics.

Regressed Prices |

Share

Timeline |

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Omega Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Omega Therapeutics' short interest history, or implied volatility extrapolated from Omega Therapeutics options trading.

## Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Omega Therapeutics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.## Build Optimal Portfolios

### Align your risk with return expectations

Please check Omega Therapeutics Correlation, Omega Therapeutics Volatility and Omega Therapeutics Alpha and Beta module to complement your research on Omega Therapeutics. Note that the Omega Therapeutics information on this page should be used as a complementary analysis to other Omega Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

## Complementary Tools for Omega Stock analysis

When running Omega Therapeutics price analysis, check to measure Omega Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Therapeutics is operating at the current time. Most of Omega Therapeutics' value examination focuses on studying past and present price action to predict the probability of Omega Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Omega Therapeutics' price. Additionally, you may evaluate how the addition of Omega Therapeutics to your portfolios can decrease your overall portfolio volatility.

Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | Go | |

Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments | Go | |

Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | Go | |

Technical AnalysisCheck basic technical indicators and analysis based on most latest market data | Go | |

Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets | Go | |

Global CorrelationsFind global opportunities by holding instruments from different markets | Go | |

CEO DirectoryScreen CEOs from public companies around the world | Go | |

Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets | Go | |

Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios | Go |

Omega Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.